Magic Red Cathepsin B Assay Kit

Background/Introduction: Magic Red® Cathepsin assay kits enable researchers to quantitate and monitor intracellular cathepsin B, K, or L activity over time in vitro. The Magic Red (MR) reagent is a non-cytotoxic substrate that fluoresces red upon cleavage by active cathepsin enzymes. Elevated cathepsin enzyme activity in serum or the extracellular matrix oft en signifies a number of gross pathological conditions. Cathepsin-mediated diseases include: Alzheimer's; numerous types of cancer; autoimmune related diseases like arthritis; and the accelerated breakdown of bone structure seen with osteoporosis1,2. Up-regulated cathepsin B and L activity has been linked to several types of cancer. These include cancer of the colon, pancreas, ovaries, breast, lung, and skin (melanoma)3-6. Upregulation of cathepsin K has been shown in lung tumors7. Increased cathepsin K activity has also been linked to degenerative bone diseases including osteopetrosis and post-menopausal osteoporosis1, 8. Cathepsins are usually characterized as members of the lysosomal cysteine protease (active site) family9 and the cathepsin family name has been synonymous with lysosomal proteolytic enzymes1. In actuality, the cathepsin family also contains members of the serine protease (cathepsin A and G) and aspartic protease (cathepsin D and E) families as well. These enzymes exist in their processed form as disulfide-linked heavy and light chain subunits with molecular weights ranging from 20-35 kDa10. Cathepsin C is the noted exception, existing as an oligomeric enzyme with a MW ~200 kDa11. Initially synthesized as inactive zymogens, cathepsins are post-translationally processed into their active configurations aft er passing through the endoplasmic reticulum and subsequent incorporation into the acidic environment of the lysosomes1, 11. Magic Red detection substrates utilize the photostable red fluorophore, cresyl violet. When bi-substituted via amide linkage to two cathepsin target peptide sequences, such as (leucine-arginine)2, the bi-substituted cresyl violet is nonfluorescent10. Following enzymatic cleavage at one or both arginine (R) amide linkage sites, the mono and non-substituted cresyl violet fluorophores generate red fluorescence when excited at 550-590 nm. Magic Red cathepsin B substrate, MR-(RR)2, is comprised of cresyl violet coupled to two pairs of the amino acid sequence, arginine-arginine (RR), which is the preferential target sequence for cathepsin B. In cathepsin K substrate, MR-(LR)2, cresyl violet is coupled to two pairs of leucinearginine (LR). MR cathepsin L substrate, MR-(FR)2, contains two pairs of phenylalanine-arginine (FR) coupled to cresyl violet. Cathepsins, like most other crucial cell survival enzymes, are somewhat permissive in the target amino acid sequence they will recognize and cleave. Although Magic Red substrates contain the amino acid target sequence preferred by a particular cathepsin enzyme, they can also recognize other active cathepsins or proteases when they are present. MBS encourages validation of cathepsin activity by an orthogonal technique. To use Magic Red, add the substrate directly to the cell culture media, incubate, and analyze. Because MR is cell-permeant, it easily penetrates the cell membrane and the membranes of the internal cellular organelles - no lysis or permeabilization steps are required. If cathepsin enzymes are active, they will cleave off the two dipeptide cathepsin targeting sequences and allow the cresyl violet fluorophore to become fluorescent upon excitation. The red fluorescent product will stay inside the cell and will oft en aggregate inside lysosomes (cathepsins are lysosomal) and other areas of low pH, such as inside the mitochondria. As protease activity progresses and more MR substrate is cleaved, the signal will intensify as the red fluorescent product accumulates within various organelles, enabling researchers to watch the color develop over time and quantify cathepsin B, K, or L activity. By varying the duration and concentration of exposure to the MR substrate, a picture can be obtained of the relative abundance of cathepsin enzymatic activity. Positive cells will fluoresce red and have pronounced red lysosomes and mitochondria. Negative cells will exhibit very low levels of background red fluorescence evenly distributed throughout the cell. This background level of substrate activity could be the result of constitutively synthesized serine proteases that target analogous amino acid sequences for hydrolysis. Please note that Magic Red substrates can undergo spontaneous hydrolysis over time, resulting in increased background fluorescence. Appropriate controls are necessary for accurate interpretation of the results. There is no interference from pro-cathepsins forms of the enzymes. If the treatment or experimental condition stimulates cathepsin activity, cells containing elevated levels of cathepsin activity will appear brighter red than cells with lower levels of cathepsin activity. The MR fluorophore, cresyl violet, fluoresces red when excited at 550-590 nm10. The red fluorescent signal can be monitored with a fluorescence microscope or plate reader. It has an optimal excitation of 592 nm and emission of 628 nm12. Hoechst 33342 is included with the kit to concurrently label nuclei aft er labeling with MR. It is revealed under a microscope using a UV-filter with excitation at 365 nm and emission at 480 nm. Acridine orange (AO) is also included in the kit to identify lysosomes and other intracellular organelles (Figures 3 and 4). It is revealed under a microscope using excitation at 480 nm and emission at >540 nm, or alternatively with excitation at 550 nm and emission at >610 nm.

Takayuki, T., S. Yonezawa, A.H. Dehdarani, and J. Tang. 1986. Comparative studies of two cathepsin B isozymes from porcine spleen. J. Biol. Chem. 261: 9368-9374. Hashimoto, Y., H. Kakegawa, Y. Narita, Y. Hachiya, T. Hayakawa, J. Kos, V. Turk, and N. Katunuma. 2001. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem. Bioph. Res. Co. 283: 334-339. Szpaderska, A.M., and A. Frankfater. 2001. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 6: 3493-3500. Kos, J., H. J. Nielsen, M. Krasovec, I.J. Christensen, N. Cimerman, R. W. Stephens, and N. Brunner. 1998. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin. Cancer Res. 4: 1511-1516.

Small volumes of Magic Red Cathepsin B assay kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS258020 is an assay kit targeting Magic Red Cathepsin B.